1-5 of 5
JW Parker
Close
Sort by
Journal Articles

Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group

WY Wong, DR Powars, EA Operskalski, J Hassett, JW Parker, S Sarnaik, CH Pegelow, MW Hilgartner, CS Johnson, Y Zhou
Journal: Blood
Blood (1995) 85 (8): 2091–2097.
https://doi.org/10.1182/blood.V85.8.2091.bloodjournal8582091
Published: 1995
Journal Articles

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group

GF Gjerset, MC Pike, JW Mosley, J Hassett, MA Fletcher, E Donegan, JW Parker, RB Counts, Y Zhou, CK Kasper
Journal: Blood
Blood (1994) 84 (5): 1666–1671.
https://doi.org/10.1182/blood.V84.5.1666.1666
Published: 1994
Journal Articles

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group

J Hassett, GF Gjerset, JW Mosley, MA Fletcher, E Donegan, JW Parker, RB Counts, LM Aledort, H Lee, MC Pike
Journal: Blood
Blood (1993) 82 (4): 1351–1357.
https://doi.org/10.1182/blood.V82.4.1351.1351
Published: 1993
Journal Articles

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group

MA Fletcher, JW Mosley, J Hassett, GF Gjerset, J Kaplan, JW Parker, E Donegan, JM Lusher, H Lee
Journal: Blood
Blood (1992) 80 (3): 831–840.
https://doi.org/10.1182/blood.V80.3.831.831
Published: 1992
Journal Articles

Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases

B Falini, I De Solas, AM Levine, JW Parker, RJ Lukes, CR Taylor
Journal: Blood
Blood (1982) 59 (5): 923–933.
https://doi.org/10.1182/blood.V59.5.923.923
Published: 1982